Leadership transitions
The following are leadership transitions at the IU Simon Comprehensive Cancer Center:
The following are leadership transitions at the IU Simon Comprehensive Cancer Center:
Katie McGill, MSM, has been named the associate director of system integration at the IU Simon Comprehensive Cancer Center. In this role, she will continue integrating the cancer center with IU Health.
Huda Salman, M.D., Ph.D., succeeds Utpal Davé, M.D., as co-leader of the Hematopoiesis and Hematologic Malignancies (HHM) research program. She will serve alongside Reuben Kapur, Ph.D., as HHM transitions from a basic science program to a translational program.
Daenique Jengelley, Ph.D., has been named a program management specialist with the cancer center’s Diversity, Equity, and Inclusion (DEI) team and the Department of Pediatrics’ Pediatric and Adolescent Comparative Effective Research program. At the cancer center, she will provide administrative support to DEI and the Plan to Enhance Diversity (PED). Jengelley earned her bachelor’s degree from Tuskegee University and her doctorate in biochemistry and molecular biology from IU School of Medicine. She can be reached at djengell@iu.edu.
Watch Ashiq Masood, M.D., talk about his research on Twitter as part of our content for Pancreatic Cancer Awareness Month.
Meet two fourth-grade students on Facebook who are among the latest cancer center donors.
Check out a highlight reel on Instagram of the 2022 End Lung Cancer Now Gathering.
For Lung Cancer Awareness Month, Francesca Duncan, M.D., discusses her research on health disparities in lung cancer on LinkedIn.
Congratulations to the following cancer center staff members who reached IU service milestones in 2022:
Kenneth Nephew, Ph.D. (TMM), has been newly appointed the Dean of the Department of Defense Ovarian Cancer Academy. His multi-year appointment will start in January. The goal of the Ovarian Cancer Academy is to develop successful, highly productive ovarian cancer researchers in a collaborative research training environment. | |
Jennifer Belsky, D.O. (CPC), received a three-year, $30,000 funding commitment from the Heroes Foundation for her research on decreasing the detrimental side effects children and teens experience while receiving cancer therapy. Read the announcement. | |
Edward Greenfield, Ph.D. (TMM), was awarded the $100,000 Kenneth and Verna Mae Jessen Award from the Big Ten Cancer Research Consortium Foundation. He was honored on Nov. 19 during the annual Big Ten CRC Summit in Columbus, Ohio. Learn more about the award in the announcement. | |
Anna Maria Storniolo, M.D. (CPC), was recently a guest on the goodMRKT Live! podcast, where she discussed breast cancer research, survival, and a future full of hope. Listen to the podcast. |
Suparna Clasen, M.D., MSCE
Associate member, Cancer Prevention and Control
Michele Coté, Ph.D., MPH
Full member, Cancer Prevention and Control
Aneesha Dasgupta, Ph.D.
Associate member, Tumor Microenvironment and Metastasis
Katy Hilts, Ph.D., MPH
Associate member, Cancer Prevention and Control
Rohan Maniar, M.D.
Associate member, Experimental and Developmental Therapeutics
Daniel Peltier, M.D., Ph.D.
Associate member, Hematopoiesis and Hematologic Malignancies
Misty Shields, M.D., Ph.D.
Associate member, Experimental and Developmental Therapeutics
Anthony Yang, M.D., M.S., FACS
Associate member, Cancer Prevention and Control